Position in PAHC
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,177,814
-$924,519 QoQ
Shares Held
37,510
-1.3% QoQ
Ownership
0.092%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#62
of 206 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 64%
Shared 0%
None 36%
Common Shares in PAHC Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026MARTINGALE ASSET MANAGEMENT L P holds $52,615,067 across 17 Drug Manufacturers - Specialty & Generic names. PAHC ranks #12 (2.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NBIX |
Neurocrine Biosciences Inc
|
69,799 | $11,763,923 | |
| 2 | ALKS |
Alkermes plc.
|
170,004 | $8,908,209 | |
| 3 | AMRX |
Amneal Pharmaceuticals, Inc.
|
283,033 | $4,899,301 | |
| 4 | UTHR |
UNITED THERAPEUTICS Corp
|
7,622 | $4,129,828 | |
| 5 | INDV |
Indivior Pharmaceuticals, Inc.
|
85,564 | $3,510,690 | |
| 6 | SUPN |
Supernus Pharmaceuticals, Inc.
|
74,348 | $3,457,925 | |
| 7 | PCRX |
Pacira BioSciences, Inc.
|
112,025 | $2,842,074 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
30,741 | $2,544,739 |
All Filings in PAHC
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,177,814 | 37,510 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,102,333 | 38,010 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,246,515 | 33,365 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,437,300 | 35,524 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $2,113,638 | 82,758 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $1,913,129 | 89,566 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $1,948,716 | 92,796 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,179,935 | 96,800 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,732,173 | 103,290 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,304,417 | 100,883 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $986,685 | 85,206 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $1,113,658 | 87,209 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,194,763 | 87,209 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $1,404,966 | 91,708 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,352,465 | 100,855 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $1,131,404 | 85,132 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $586,143 | 30,640 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $590,978 | 29,623 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $596,590 | 29,216 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $629,441 | 29,222 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $1,101,309 | 38,134 | Shares | Sole | 2021-08-13 | |
| 2020-12-31 | $1,090,413 | 56,149 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $2,115,126 | 121,559 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $5,024,295 | 191,256 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $4,651,709 | 192,458 | Shares | Sole | 2020-05-11 | |
| No filing history on record for this holder in this stock. | ||||||